The Cancer Letter

Inside information on cancer research and drug development

Clinical Roundup

Roswell Park, Wilmot Cancer Institute collaborate on large study of immunotherapy in Black cancer patients

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print
BYLINE
IN THIS ISSUE
DOWNLOAD PDFTABLE OF CONTENTS

Roswell Park Comprehensive Cancer Center and University of Rochester’s Wilmot Cancer Institute received a $2.08 million grant from NCI to research whether Black and white cancer patients respond differently to immune checkpoint inhibitors. 

To access this subscriber-only content please log in or subscribe.

If your institution has a site license, log in with IP-login or register for a sponsored account.*
*Not all site licenses are enrolled in sponsored accounts.

Login Subscribe
Table of Contents

YOU MAY BE INTERESTED IN

Table of Contents

Login

Site license subscribers:
Log in with your IP | Register a sponsored account